About HongYe |
SiChuan HongYe Medical Investment & Management Co.Ltd was founded in 1999 , as a
result of rouming ourselves for vigorous efforts to make the company
prosperous for almost ten years , now it has become a large-scale
national medical treatment industrial development group company
collected the medical treatment investment , research , development , plot
and medical treatment organization management with an
integral whole.the company now has 10
subsidiary |
|
hospitals , over hundred million fixed
assets and the total incomes in
2007 is more than three hundred million.the company has 4,000 cure and nurse personnel(62 experts enjoy state council and local governments allowance and 618 high in rank professional job title doctors),meanwhile they possess a lot of young and middle age backbone doctors in their prime charged with many science research proects related to government.
The company has
invested and managed more than ten hospitals,including ChengDu JiMin women's Hospital, ChangSha HongYe dermatosis Hospital, XinJiang Oriental dermatosis Hospital, DaLi HuaXi dermatosis Hospital, LiJiang HengRui dermatosis Hospital and so on. The subordinate hospital has installed 4,000 beds, the annual, includes internal medicine
department, surgical department, cerebral neurosurgery department, oncology department, kidney disease department, department of orthopedics, diabetes rehabilitation centre, cardiovascular department, anus and intestines department, mammary gland disease department, andrology centre, urological department, gynecology centre,sterility centre, reproduction plastic centre, cosmetology plastic department, liver disease centre, prostate department, rheumatism department, dermatological department, traditional Chinese medical department, department of pediatrics, neurosurgery, otolaryngdogical department, department of stomatology,juvenile eyesight rehabilitation centre and so on.
At present,the group is booming developing,the absolute leadership in west market makes the group have the power to expand in whole China.The high rank of the group has made the goal that ascend to leader position in 10 years and will invest large scale of treasury into celebral,tumor and cardiovascular field of hi-tech medical treatment.We will try our best to make the company become first place in the field of domestic medical treatment investment.
|
